Corvus Pharmaceuticals, Inc. ( NASDAQ:CRVS – Get Rating ) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 973,100 shares, an increase of 113.6% from the May 15th total of 455,500 shares. Approximately 2.8% of the company's stock are sold short. Based on an average daily trading volume, of 862,100 shares, the short-interest ratio is currently 1.1 days. Wall Street Analyst Weigh In CRVS has been the topic of several research reports.

https://www.dailypolitical.com/2023/06/14/short-interest-in-corvus-pharmaceuticals-inc-nasdaqcrvs-increases-by-113-6.html

#dailypolitical